Advertisement

Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study

Published:November 30, 2021DOI:https://doi.org/10.1016/j.amepre.2021.08.004

      Introduction

      Smoking is independently associated with erectile dysfunction and cardiovascular disease. Given existing similarities in the constituents of e-cigarettes or ENDS and cigarettes, this study examines the association between ENDS use and erectile dysfunction.

      Methods

      Data from Wave 4 (2016–2018) of the Population Assessment of Tobacco and Health study were analyzed in 2020. Male participants aged ≥20 years who responded to the erectile dysfunction question were included. Multivariable logistic regression models examined the association of ENDS use with erectile dysfunction within the full sample and in a restricted sample (adults aged 20–65 years with no previous cardiovascular disease diagnosis) while adjusting for multiple risk factors.

      Results

      The proportion of erectile dysfunction varied from 20.7% (full sample) to 10.2% (restricted sample). The prevalence of current ENDS use within the full and restricted samples was 4.8% and 5.6%, respectively, with 2.1% and 2.5%, respectively, reporting daily use. Current daily ENDS users were more likely to report erectile dysfunction than never users in both the full (AOR=2.24, 95% CI=1.50, 3.34) and restricted (AOR=2.41, 95% CI=1.55, 3.74) samples. In the full sample, cardiovascular disease history (versus not present) and age ≥65 years (versus age 20–24 years) were associated with erectile dysfunction (AOR=1.39, 95% CI=1.10, 1.77; AOR= 17.4, 95% CI=12.15, 24.91), whereas physical activity was associated with lower odds of erectile dysfunction in both samples (AOR range=0.44−0.58).

      Conclusions

      The use of ENDS seems to be associated with erectile dysfunction independent of age, cardiovascular disease, and other risk factors. While ENDS remain under evaluation for harm reduction and smoking-cessation potential, ENDS users should be informed about the possible association between ENDS use and erectile dysfunction.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • NIH Consensus Conference
        Impotence. NIH consensus development panel on impotence.
        JAMA. 1993; 270: 83-90https://doi.org/10.1001/jama.1993.03510010089036
        • Ayta IA
        • McKinlay JB
        • Krane RJ
        The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences.
        BJU Int. 1999; 84: 50-56https://doi.org/10.1046/j.1464-410x.1999.00142.x
        • Johannes CB
        • Araujo AB
        • Feldman HA
        • Derby CA
        • Kleinman KP
        • McKinlay JB
        Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.
        J Urol. 2000; 163: 460-463https://doi.org/10.1016/s0022-5347(05)67900-1
        • Selvin E
        • Burnett AL
        • Platz EA
        Prevalence and risk factors for erectile dysfunction in the U.S.
        Am J Med. 2007; 120: 151-157https://doi.org/10.1016/j.amjmed.2006.06.010
        • Jeremy JY
        • Mikhailidis DP.
        Cigarette smoking and erectile dysfunction.
        J R Soc Promot Health. 1998; 118: 151-155https://doi.org/10.1177/146642409811800305
        • Uddin SMI
        • Mirbolouk M
        • Dardari Z
        • et al.
        Erectile dysfunction as an independent predictor of future cardiovascular events: the multi-ethnic study of atherosclerosis.
        Circulation. 2018; 138: 540-542https://doi.org/10.1161/CIRCULATIONAHA.118.033990
        • Orimoloye OA
        • Feldman DI
        • Blaha MJ.
        Erectile dysfunction links to cardiovascular disease-defining the clinical value.
        Trends Cardiovasc Med. 2019; 29: 458-465https://doi.org/10.1016/j.tcm.2019.01.002
        • Seidman SN
        • Roose SP.
        The relationship between depression and erectile dysfunction.
        Curr Psychiatry Rep. 2000; 2: 201-205https://doi.org/10.1007/s11920-996-0008-0
        • Solomon H
        • Man JW
        • Jackson G.
        Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator.
        Heart. 2003; 89: 251-253https://doi.org/10.1136/heart.89.3.251
        • Biebel MG
        • Burnett AL
        • Sadeghi-Nejad H.
        Male sexual function and smoking.
        Sex Med Rev. 2016; 4: 366-375https://doi.org/10.1016/j.sxmr.2016.05.001
        • Milenkovic U
        • Albersen M.
        Smoking and men's health.
        (eds)in: Yafi FA Yafi NR Effects of Lifestyle on Men's Health. Academic Press, Cambridge, MA2019: 303-319https://doi.org/10.1016/b978-0-12-816665-9.00016-0
        • Bacon CG
        • Mittleman MA
        • Kawachi I
        • Giovannucci E
        • Glasser DB
        • Rimm EB.
        Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study.
        Ann Intern Med. 2003; 139: 161-168https://doi.org/10.7326/0003-4819-139-3-200308050-00005
        • Michael Pittilo R
        Cigarette smoking, endothelial injury and cardiovascular disease.
        Int J Exp Pathol. 2000; 81: 219-230https://doi.org/10.1046/j.1365-2613.2000.00162.x
        • Levine LA
        • Gerber GS.
        Acute vasospasm of penile arteries in response to cigarette smoking.
        Urology. 1990; 36: 99-100https://doi.org/10.1016/0090-4295(90)80326-i
        • Noel JK
        • Rees VW
        • Connolly GN.
        Electronic cigarettes: a new ‘tobacco’ industry?.
        Tob Control. 2011; 20: 81https://doi.org/10.1136/tc.2010.038562
        • Warner KE
        • Mendez D.
        E-cigarettes: comparing the possible risks of increasing smoking initiation with the potential benefits of increasing smoking cessation.
        Nicotine Tob Res. 2019; 21: 41-47https://doi.org/10.1093/ntr/nty062
        • Brett J
        • Davies EL
        • Matley F
        • et al.
        Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK.
        BMJ Open. 2020; 10e037637https://doi.org/10.1136/bmjopen-2020-037637
        • Adriaens K
        • Belmans E
        • Van Gucht D
        • Baeyens F.
        Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: e-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids.
        Harm Reduct J. 2021; 18: 1-12https://doi.org/10.1186/s12954-021-00475-7
        • Corona G
        • Sansone A
        • Pallotti F
        • et al.
        People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction.
        J Endocrinol Invest. 2020; 43: 1391-1408https://doi.org/10.1007/s40618-020-01257-x
        • Virag R
        • Bouilly P
        • Frydman D.
        Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.
        Lancet. 1985; 1: 181-184https://doi.org/10.1016/s0140-6736(85)92023-9
        • Powell JT
        • Higman DJ.
        Smoking, nitric oxide and the endothelium.
        Br J Surg. 1994; 81: 785-787https://doi.org/10.1002/bjs.1800810602
        • Kovac JR
        • Labbate C
        • Ramasamy R
        • Tang D
        • Lipshultz LI.
        Effects of cigarette smoking on erectile dysfunction.
        Andrologia. 2015; 47: 1087-1092https://doi.org/10.1111/and.12393
        • Farsalinos KE
        • Spyrou A
        • Tsimopoulou K
        • Stefopoulos C
        • Romagna G
        • Voudris V.
        Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices.
        Sci Rep. 2014; 4: 4133https://doi.org/10.1038/srep04133
        • Grana R
        • Benowitz N
        • Glantz SA.
        E-cigarettes: a scientific review.
        Circulation. 2014; 129: 1972-1986https://doi.org/10.1161/CIRCULATIONAHA.114.007667
        • Benowitz NL
        • Burbank AD.
        Cardiovascular toxicity of nicotine: implications for electronic cigarette use.
        Trends Cardiovasc Med. 2016; 26: 515-523https://doi.org/10.1016/j.tcm.2016.03.001
        • Abafalvi L
        • Pénzes M
        • Urbán R
        • et al.
        Perceived health effects of vaping among Hungarian adult e-cigarette-only and dual users: a cross-sectional internet survey.
        BMC Public Health. 2019; 19: 302https://doi.org/10.1186/s12889-019-6629-0
        • Hyland A
        • Ambrose BK
        • Conway KP
        • et al.
        Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.
        Tob Control. 2017; 26: 371-378https://doi.org/10.1136/tobaccocontrol-2016-052934
      1. Population Assessment of Tobacco and Health (PATH) study [United States] public-use files.
        NIH, National Addiction & HIV Data Archive Program, October 21, 2020 (https://www.icpsr.umich.edu/web/NAHDAP/studies/36498/datadocumentation#:∼:text=The%20Population%20Assessment%20of%20Tobacco%20and%20Health%20(PATH)%20Study%20is,youth%20in%20the%20United%20States. Accessed August 26, 2021)
        • Albaugh J
        • Lewis JH.
        Insights into the management of erectile dysfunction: part I.
        Urol Nurs. 1999; 19 (https://www.suna.org/download/members/unjarticles/1999/99dec/Mastheads_D99.pdf. Accessed August 1, 2021): 241-245
        • Hodges LD
        • Kirby M
        • Solanki J
        • O'Donnell J
        • Brodie DA
        The temporal relationship between erectile dysfunction and cardiovascular disease.
        Int J Clin Pract. 2007; 61: 2019-2025https://doi.org/10.1111/j.1742-1241.2007.01629.x
        • Mannino DM
        • Klevens RM
        • Flanders WD.
        Cigarette smoking: an independent risk factor for impotence?.
        Am J Epidemiol. 1994; 140: 1003-1008https://doi.org/10.1093/oxfordjournals.aje.a117189
        • Lam TH
        • Abdullah AS
        • Ho LM
        • Yip AW
        • Fan S.
        Smoking and sexual dysfunction in Chinese males: findings from men's health survey.
        Int J Impot Res. 2006; 18: 364-369https://doi.org/10.1038/sj.ijir.3901436
        • Szumilas K
        • Szumilas P
        • Grzywacz A
        • Wilk A.
        The effects of e-cigarette vapor components on the morphology and function of the male and female reproductive systems: a systematic review.
        Int J Environ Res Public Health. 2020; 17: 6152https://doi.org/10.3390/ijerph17176152
        • Gilbert DG
        • Hagen RL
        • D'Agostino JA
        The effects of cigarette smoking on human sexual potency.
        Addict Behav. 1986; 11: 431-434https://doi.org/10.1016/0306-4603(86)90022-5
        • Cao S
        • Gan Y
        • Dong X
        • Liu J
        • Lu Z.
        Association of quantity and duration of smoking with erectile dysfunction: a dose–response meta-analysis.
        J Sex Med. 2014; 11: 2376-2384https://doi.org/10.1111/jsm.12641
        • Pearson JL
        • Richardson A
        • Niaura RS
        • Vallone DM
        • Abrams DB.
        E-cigarette awareness, use, and harm perceptions in U.S. adults.
        Am J Public Health. 2012; 102: 1758-1766https://doi.org/10.2105/AJPH.2011.300526
        • Obisesan OH
        • Osei AD
        • Uddin SMI
        • et al.
        Trends in e-cigarette use in adults in the United States, 2016-2018.
        JAMA Intern Med. 2020; 180: 1394-1398https://doi.org/10.1001/jamainternmed.2020.2817
        • Amrock SM
        • Zakhar J
        • Zhou S
        • Weitzman M.
        Perception of e-cigarette harm and its correlation with use among U.S. adolescents.
        Nicotine Tob Res. 2014; 17: 330-336https://doi.org/10.1093/ntr/ntu156
        • Rose SW
        • Barker DC
        • D'Angelo H
        • et al.
        The availability of electronic cigarettes in U.S. retail outlets, 2012: results of two national studies.
        Tob Control. 2014; 23: iii10-iii16https://doi.org/10.1136/tobaccocontrol-2013-051461
        • Dawkins L
        • Turner J
        • Roberts A
        • Soar K.
        ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users.
        Addiction. 2013; 108: 1115-1125https://doi.org/10.1111/add.12150
        • Dockrell M
        • Morrison R
        • Bauld L
        • McNeill A.
        E-cigarettes: prevalence and attitudes in Great Britain.
        Nicotine Tob Res. 2013; 15: 1737-1744https://doi.org/10.1093/ntr/ntt057
        • Etter JF
        • Bullen C.
        Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy.
        Addiction. 2011; 106: 2017-2028https://doi.org/10.1111/j.1360-0443.2011.03505.x
        • Bhatnagar A
        • Whitsel LP
        • Ribisl KM
        • et al.
        Electronic cigarettes: a policy statement from the American Heart Association.
        Circulation. 2014; 130: 1418-1436https://doi.org/10.1161/CIR.0000000000000107
        • Hajek P
        • Phillips-Waller A
        • Przulj D
        • et al.
        A randomized trial of e-cigarettes versus nicotine-replacement therapy.
        N Engl J Med. 2019; 380: 629-637https://doi.org/10.1056/NEJMoa1808779
        • Chen R
        • Pierce JP
        • Leas EC
        • et al.
        Use of electronic cigarettes to aid long-term smoking cessation in the United States: prospective evidence from the PATH Cohort Study.
        Am J Epidemiol. 2020; 189: 1529-1537https://doi.org/10.1093/aje/kwaa161
        • Okuyemi KS
        • Harris KJ
        • Scheibmeir M
        • Choi WS
        • Powell J
        • Ahluwalia JS.
        Light smokers: issues and recommendations.
        Nicotine Tob Res. 2002; 4: S103-S112https://doi.org/10.1080/1462220021000032726
        • Franck C
        • Filion KB
        • Kimmelman J
        • Grad R
        • Eisenberg MJ.
        Ethical considerations of e-cigarette use for tobacco harm reduction.
        Respir Res. 2016; 17: 53https://doi.org/10.1186/s12931-016-0370-3
        • Xie Z
        • Ossip DJ
        • Rahman I
        • Li D.
        Use of electronic cigarettes and self-reported chronic obstructive pulmonary disease diagnosis in adults.
        Nicotine Tob Res. 2020; 22: 1155-1161https://doi.org/10.1093/ntr/ntz234
        • Polosa R
        • Morjaria JB
        • Prosperini U
        • et al.
        COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up.
        Ther Adv Chronic Dis. 2020; 11 (2040622320961617)https://doi.org/10.1177/2040622320961617
        • Goniewicz ML
        • Knysak J
        • Gawron M
        • et al.
        Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.
        Tob Control. 2014; 23: 133-139https://doi.org/10.1136/tobaccocontrol-2012-050859
        • Schripp T
        • Markewitz D
        • Uhde E
        • Salthammer T.
        Does e-cigarette consumption cause passive vaping?.
        Indoor Air. 2013; 23: 25-31https://doi.org/10.1111/j.1600-0668.2012.00792.x
        • Flouris AD
        • Chorti MS
        • Poulianiti KP
        • et al.
        Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function.
        Inhal Toxicol. 2013; 25: 91-101https://doi.org/10.3109/08958378.2012.758197
        • Chang SW
        • Fine R
        • Siegel D
        • Chesney M
        • Black D
        • Hulley SB.
        The impact of diuretic therapy on reported sexual function.
        Arch Intern Med. 1991; 151: 2402-2408https://doi.org/10.1001/archinte.1991.00400120048008
        • Ko DT
        • Hebert PR
        • Coffey CS
        • Sedrakyan A
        • Curtis JP
        • Krumholz HM.
        Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.
        JAMA. 2002; 288: 351-357https://doi.org/10.1001/jama.288.3.351
        • Rosen RC
        • Lane RM
        • Menza M.
        Effects of SSRIs on sexual function: a critical review.
        J Clin Psychopharmacol. 1999; 19: 67-85https://doi.org/10.1097/00004714-199902000-00013
        • Kitzen JM
        • McConaha JL
        • Bookser ML
        • Pergolizzi Jr, JV
        • Taylor Jr, R
        • Raffa RB
        E-cigarettes for smoking cessation: do they deliver?.
        J Clin Pharm Ther. 2019; 44: 650-655https://doi.org/10.1111/jcpt.12833
        • Wakefield M
        • Flay B
        • Nichter M
        • Giovino G.
        Effects of anti-smoking advertising on youth smoking: a review.
        J Health Commun. 2003; 8: 229-247https://doi.org/10.1080/10810730305686
        • Brennan E
        • Gibson LA
        • Kybert-Momjian A
        • Liu J
        • Hornik RC.
        Promising themes for antismoking campaigns targeting youth and young adults.
        Tob Regul Sci. 2017; 3: 29-46https://doi.org/10.18001/TRS.3.1.4